000305399 001__ 305399
000305399 005__ 20251017115451.0
000305399 0247_ $$2doi$$a10.1016/j.jaad.2025.10.036
000305399 0247_ $$2pmid$$apmid:41093058
000305399 0247_ $$2ISSN$$a0190-9622
000305399 0247_ $$2ISSN$$a1097-6787
000305399 037__ $$aDKFZ-2025-02136
000305399 041__ $$aEnglish
000305399 082__ $$a610
000305399 1001_ $$aYu, Wesley Y$$b0
000305399 245__ $$aCP-GEP Identifies High-Risk T1a Melanoma Patients Beyond Established Adverse Features.
000305399 260__ $$aAmsterdam [u.a.]$$bElsevier$$c2025
000305399 3367_ $$2DRIVER$$aarticle
000305399 3367_ $$2DataCite$$aOutput Types/Journal article
000305399 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1760623100_219522
000305399 3367_ $$2BibTeX$$aARTICLE
000305399 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000305399 3367_ $$00$$2EndNote$$aJournal Article
000305399 500__ $$aepub
000305399 536__ $$0G:(DE-HGF)POF4-311$$a311 - Zellbiologie und Tumorbiologie (POF4-311)$$cPOF4-311$$fPOF IV$$x0
000305399 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000305399 650_7 $$2Other$$aCP-GEP
000305399 650_7 $$2Other$$aMerlin Assay
000305399 650_7 $$2Other$$amelanoma
000305399 650_7 $$2Other$$ametastasis
000305399 650_7 $$2Other$$arisk prediction
000305399 650_7 $$2Other$$asentinel lymph node biopsy
000305399 7001_ $$aPazhava, Ani$$b1
000305399 7001_ $$aWeitemeyer, Marie B$$b2
000305399 7001_ $$aHölmich, Lisbet R$$b3
000305399 7001_ $$aJohansson, Iva$$b4
000305399 7001_ $$aBagge, Roger Olofsson$$b5
000305399 7001_ $$0P:(DE-He78)a229f7724466e7efadf4a1ace1ff8af3$$aUtikal, Jochen$$b6$$udkfz
000305399 7001_ $$aVenna, Suraj$$b7
000305399 7001_ $$aJackson, Julie$$b8
000305399 7001_ $$aAmaral, Teresa$$b9
000305399 7001_ $$avan Akkooi, Alexander$$b10
000305399 7001_ $$aKolodney, Michael S$$b11
000305399 7001_ $$aMcArthur, Grant A$$b12
000305399 7001_ $$aMeves, Alexander$$b13
000305399 773__ $$0PERI:(DE-600)2001404-1$$a10.1016/j.jaad.2025.10.036$$gp. S019096222503004X$$pnn$$tJournal of the American Academy of Dermatology$$vnn$$x0190-9622$$y2025
000305399 909CO $$ooai:inrepo02.dkfz.de:305399$$pVDB
000305399 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a229f7724466e7efadf4a1ace1ff8af3$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000305399 9131_ $$0G:(DE-HGF)POF4-311$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vZellbiologie und Tumorbiologie$$x0
000305399 9141_ $$y2025
000305399 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2024-12-27$$wger
000305399 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ AM ACAD DERMATOL : 2022$$d2024-12-27
000305399 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-27
000305399 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-27
000305399 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-27
000305399 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-27
000305399 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2024-12-27
000305399 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2024-12-27
000305399 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-27
000305399 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-27
000305399 915__ $$0StatID:(DE-HGF)9910$$2StatID$$aIF >= 10$$bJ AM ACAD DERMATOL : 2022$$d2024-12-27
000305399 9201_ $$0I:(DE-He78)A370-20160331$$kA370$$lKKE Dermatoonkologie$$x0
000305399 980__ $$ajournal
000305399 980__ $$aVDB
000305399 980__ $$aI:(DE-He78)A370-20160331
000305399 980__ $$aUNRESTRICTED